S&P Futures
5,974.50 +16.25 (+0.27%) Dow Futures
43,998.00 +97.00 (+0.22%) Nasdaq Futures
20,969.00 +75.00 (+0.36%) Russell 2000 Futures
2,423.00 +17.20 (+0.71%) Crude Oil
71.05 -0.64 (-0.89%) Gold
2,675.20 -1.10 (-0.04%)
RLMD Nov 2024 10.000 call
| Previous Close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.4500 |
| Strike | 10.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.1000 - 0.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 339 |
GlobeNewswireRelmada Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024
CORAL GABLES, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced plans to host a conference call and webcast on Thursday, November 7, 2024 at 4:30 PM ET to discuss recent business progress and financial results for the third quarter ended September 30, 2024. Conference Call and Webcast Information:Date: Thursday, November 7, 2024 at 4:30 PM ETPart
Simply Wall St.3 US Penny Stocks To Monitor In October 2024
As the major U.S. stock indexes hover near record levels, investors are keenly observing market movements and economic indicators for signs of stability and growth. Penny stocks, although an antiquated term, continue to capture interest by offering potential growth opportunities at lower price points. When these smaller or newer companies boast strong financial health and solid fundamentals, they present a unique chance to discover value in the market's less-traveled paths.
